Determinants of glutamine dependence and utilization by normal and tumor-derived breast cell lines - PubMed (original) (raw)

Determinants of glutamine dependence and utilization by normal and tumor-derived breast cell lines

C L Collins et al. J Cell Physiol. 1998 Jul.

Abstract

A continual supply of the amino acid glutamine (GLN) may be necessary for cancerous cell growth. GLN plays a central role in multiple metabolic pathways and has long been considered an essential component of tissue culture media. However, the GLN requirements of tumor cell lines and the factors that determine a cell's need for GLN have not been comprehensively studied. Also, it remains unclear how various metabolic pathways contribute to GLN consumption. In the present study, possible determinants of GLN metabolism were examined in seven breast cell lines, two derived from immortalized normal tissue and five of tumor origin. These cells exhibited different dependencies on media GLN concentration for growth and a wide range of GLN utilization rates. GLN uptake was facilitated by a single, common transporter functionally defined as System ASC. However, the affinities for GLN exhibited by this transporter differed appreciably between cell lines. Furthermore, the concentration at which media GLN became a limiting factor for cellular proliferation correlated with transporter affinity. The origin of the cell lines was not a determinant of GLN metabolism because immortalized cells of nontumor origin exhibited GLN dependence and utilization rates comparable to those of tumor-derived cells. The rates of CO2 production from GLN were similar for each cell lines. Rates of GLN disappearance and glutamate appearance in media were strongly correlated, with 32-80% of media GLN converted to glutamate. Both rates were directly affected by media cystine concentration, suggesting that a large portion of glutamate efflux was coupled with cystine import through the amino acid transport system x(c)-. These results demonstrated that cell growth is a function of GLN influx and suggest that GLN is used to supply glutamate and cystine, perhaps for glutathione synthesis.

PubMed Disclaimer

Cited by

Glutamine metabolism controls amphiregulin-facilitated chemoresistance to cisplatin in human chondrosarcoma.
Wu YY, Law YY, Huang YW, Tran NB, Lin CY, Lai CY, Huang YL, Tsai CH, Ko CY, Chou MC, Huang WC, Cheng FJ, Fong YC, Tang CH. Wu YY, et al. Int J Biol Sci. 2023 Oct 9;19(16):5174-5186. doi: 10.7150/ijbs.86116. eCollection 2023. Int J Biol Sci. 2023. PMID: 37928274 Free PMC article.
Colorectal cancer-associated T cell receptor repertoire abnormalities are linked to gut microbiome shifts and somatic cell mutations.
Cao Y, Wang J, Hou W, Ding Y, Zhu Y, Zheng J, Huang Q, Cao Z, Xie R, Wei Q, Qin H. Cao Y, et al. Gut Microbes. 2023 Dec;15(2):2263934. doi: 10.1080/19490976.2023.2263934. Epub 2023 Oct 5. Gut Microbes. 2023. PMID: 37795995 Free PMC article.
Glutathione limits RUNX2 oxidation and degradation to regulate bone formation.
Hu G, Yu Y, Sharma D, Pruett-Miller SM, Ren Y, Zhang GF, Karner CM. Hu G, et al. JCI Insight. 2023 Aug 22;8(16):e166888. doi: 10.1172/jci.insight.166888. JCI Insight. 2023. PMID: 37432749 Free PMC article.
Neddylation inhibition induces glutamine uptake and metabolism by targeting CRL3SPOP E3 ligase in cancer cells.
Zhou Q, Lin W, Wang C, Sun F, Ju S, Chen Q, Wang Y, Chen Y, Li H, Wang L, Hu Z, Jin H, Wang X, Sun Y. Zhou Q, et al. Nat Commun. 2022 May 31;13(1):3034. doi: 10.1038/s41467-022-30559-2. Nat Commun. 2022. PMID: 35641493 Free PMC article.
Increased Ammonium Toxicity in Response to Exogenous Glutamine in Metastatic Breast Cancer Cells.
Kiesel VA, Sheeley MP, Donkin SS, Wendt MK, Hursting SD, Teegarden D. Kiesel VA, et al. Metabolites. 2022 May 23;12(5):469. doi: 10.3390/metabo12050469. Metabolites. 2022. PMID: 35629973 Free PMC article.

Determinants of glutamine dependence and utilization by normal and tumor-derived breast cell lines - PubMed (original) (raw)